BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15167588)

  • 1. Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody.
    Appel MC; Banuelos SJ; Greiner DL; Shultz LD; Mordes JP; Rossini AA
    Transplantation; 2004 May; 77(9):1341-9. PubMed ID: 15167588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
    Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
    Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD mice have a generalized defect in their response to transplantation tolerance induction.
    Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
    Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells.
    Gordon EJ; Woda BA; Shultz LD; Rossini AA; Greiner DL; Mordes JP
    Transplantation; 2001 Jan; 71(2):319-27. PubMed ID: 11213080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody.
    Gordon EJ; Markees TG; Phillips NE; Noelle RJ; Shultz LD; Mordes JP; Rossini AA; Greiner DL
    Diabetes; 1998 Aug; 47(8):1199-206. PubMed ID: 9703317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of porcine islet xenografts in mice using sertoli cells and monoclonal antibodies.
    Ramji QA; Bayrack K; Arefanian H; Marcet-Palacios M; Bleackley RC; Rajotte RV; Rayat GR
    Transplantation; 2011 Dec; 92(12):1309-15. PubMed ID: 22037619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine Islet-Specific Tolerance Induced by the Combination of Anti-LFA-1 and Anti-CD154 mAbs Is Dependent on PD-1.
    Arefanian H; Tredget EB; Mok DC; Ramji Q; Rafati S; Rodriguez-Barbosa J; Korbutt GS; Rajotte RV; Gill RG; Rayat GR
    Cell Transplant; 2016; 25(2):327-42. PubMed ID: 26109574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice.
    Arefanian H; Tredget EB; Rajotte RV; Gill RG; Korbutt GS; Rayat GR
    Diabetes; 2010 Apr; 59(4):958-66. PubMed ID: 20086231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-graft porcine-specific CD4
    Yoon IH; Chung H; Kim HJ; Nam HY; Shin JS; Kim YH; Park CG
    Xenotransplantation; 2019 Sep; 26(5):e12533. PubMed ID: 31111577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB.
    Rayat GR; Gill RG
    Diabetes; 2005 Feb; 54(2):443-51. PubMed ID: 15677502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies.
    Kobayashi T; Harb G; Rayat GR
    Transplantation; 2005 Sep; 80(6):821-7. PubMed ID: 16210971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti-CD154 mAb.
    Safley SA; Barber GF; Holdcraft RW; Gazda LS; Duncanson S; Poznansky MC; Sambanis A; Weber CJ
    Xenotransplantation; 2020 Jul; 27(4):e12577. PubMed ID: 31903659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
    Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
    Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.